HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Yoshida Selected Research

Vimentin

1/2021Endometrial epithelial-mesenchymal transition (EMT) by menstruation-related inflammatory factors during hypoxia.
12/2000Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat.
2/2000Thrombin inhibitor ameliorates secondary damage in rat brain injury: suppression of inflammatory cells and vimentin-positive astrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Yoshida Research Topics

Disease

54Neoplasms (Cancer)
01/2023 - 01/2000
16Carcinoma (Carcinomatosis)
04/2018 - 01/2000
10Necrosis
09/2019 - 01/2000
10Stomach Neoplasms (Stomach Cancer)
09/2015 - 03/2000
7Hypoxia (Hypoxemia)
01/2021 - 06/2000
7Breast Neoplasms (Breast Cancer)
01/2017 - 06/2000
7Hypertension (High Blood Pressure)
12/2016 - 03/2000
7Neoplasm Metastasis (Metastasis)
06/2013 - 06/2000
7Myocardial Infarction
03/2008 - 01/2000
6Rheumatoid Arthritis
09/2019 - 08/2000
6Infections
04/2014 - 12/2000
6Carcinogenesis
01/2003 - 10/2000
5Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 01/2000
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2021 - 12/2000
5Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2002
5Fibrosis (Cirrhosis)
01/2021 - 02/2001
5Pathologic Constriction (Stenosis)
06/2016 - 12/2000
5Tongue Neoplasms (Tongue Neoplasm)
01/2003 - 05/2000
5Prostatic Neoplasms (Prostate Cancer)
01/2002 - 09/2000
5Ischemia
11/2001 - 10/2000
4Pancreatic Neoplasms (Pancreatic Cancer)
04/2021 - 10/2001
4Leukemia
01/2016 - 10/2000
4Disease Progression
09/2015 - 03/2000
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2009 - 11/2001
4Arthritis (Polyarthritis)
11/2007 - 12/2000
4Lung Neoplasms (Lung Cancer)
09/2007 - 07/2001
4Chronic Kidney Failure (Chronic Renal Failure)
11/2006 - 03/2001
4Lymphatic Metastasis
06/2003 - 01/2000
3Urinary Bladder Neoplasms (Bladder Cancer)
10/2022 - 04/2000
3Hypersensitivity (Allergy)
07/2022 - 05/2000
3Inflammation (Inflammations)
01/2021 - 12/2002
3Leukoencephalopathies
01/2020 - 01/2017
3Melanoma (Melanoma, Malignant)
12/2015 - 04/2001
3Liver Diseases (Liver Disease)
04/2014 - 02/2001
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2014 - 07/2001
3Wounds and Injuries (Trauma)
01/2014 - 05/2000
3Hemorrhage
05/2008 - 11/2000
3Heart Failure
11/2007 - 10/2000
3Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2007 - 02/2000
3Spermatic Cord Torsion (Testicular Torsion)
05/2003 - 11/2000
3Lymphoma (Lymphomas)
03/2002 - 08/2000
3Infarction (Infarctions)
09/2001 - 08/2000
3Sleep Apnea Syndromes (Sleep Apnea)
08/2001 - 02/2000
3Coronary Artery Disease (Coronary Atherosclerosis)
03/2001 - 12/2000
2Mouth Neoplasms (Oral Cancer)
04/2023 - 06/2000
2Intellectual Disability (Idiocy)
01/2022 - 05/2006
2Body Weight (Weight, Body)
10/2021 - 03/2001

Drug/Important Bio-Agent (IBA)

15DNA (Deoxyribonucleic Acid)IBA
01/2017 - 04/2000
10Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2000
7Phosphotransferases (Kinase)IBA
01/2020 - 06/2000
7Messenger RNA (mRNA)IBA
09/2014 - 06/2000
6Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 12/2000
6ThrombinFDA Link
01/2021 - 02/2000
5Cisplatin (Platino)FDA LinkGeneric
10/2021 - 12/2000
5CollagenIBA
01/2021 - 08/2000
5Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2002
5Antihypertensive Agents (Antihypertensives)IBA
12/2016 - 03/2001
4Peptides (Polypeptides)IBA
01/2013 - 04/2006
3Immunoglobulin E (IgE)IBA
07/2022 - 05/2000
3TegafurIBA
01/2021 - 10/2001
3VimentinIBA
01/2021 - 02/2000
3Macrophage Colony-Stimulating FactorIBA
01/2020 - 01/2017
3Interleukin-6 (Interleukin 6)IBA
09/2019 - 05/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 10/2001
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 12/2001
3Alanine Transaminase (SGPT)IBA
01/2016 - 03/2000
3Irinotecan (Camptosar)FDA LinkGeneric
09/2015 - 08/2004
3Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 07/2000
3AntigensIBA
01/2014 - 01/2000
3AntibodiesIBA
06/2010 - 02/2001
3Therapeutic UsesIBA
05/2009 - 02/2000
3EnzymesIBA
11/2007 - 07/2001
3NF-kappa B (NF-kB)IBA
07/2004 - 04/2001
3Adrenal Cortex Hormones (Corticosteroids)IBA
05/2004 - 08/2000
3Fas Ligand Protein (Fas Ligand)IBA
02/2004 - 02/2001
3Protein Kinases (Protein Kinase)IBA
08/2001 - 06/2000
3fodrinIBA
08/2001 - 01/2000
3Mitochondrial DNA (mtDNA)IBA
05/2001 - 03/2000
3Methotrexate (Mexate)FDA LinkGeneric
02/2001 - 03/2000
3CaspasesIBA
02/2001 - 11/2000
2Antineoplastic Agents (Antineoplastics)IBA
10/2022 - 05/2009
2AllergensIBA
07/2022 - 02/2019
2Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 11/2000
2Docetaxel (Taxotere)FDA Link
10/2021 - 07/2010
2C-Reactive ProteinIBA
10/2021 - 05/2004

Therapy/Procedure

40Therapeutics
10/2022 - 02/2000
13Drug Therapy (Chemotherapy)
10/2021 - 02/2000
6Adjuvant Chemotherapy
01/2021 - 04/2001
6Brachytherapy
10/2001 - 05/2000
5Nephrectomy
11/2015 - 02/2000
5Kidney Transplantation
01/2014 - 01/2000
4Radiotherapy
10/2022 - 08/2000
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2008 - 02/2000
4Aftercare (After-Treatment)
07/2001 - 03/2000
3Transplantation
01/2018 - 03/2001
3Combination Drug Therapy (Combination Chemotherapy)
05/2015 - 06/2007
3Catheters
05/2012 - 01/2000
3Gastrectomy
07/2010 - 01/2000
3Segmental Mastectomy (Lumpectomy)
09/2007 - 09/2000
3Hepatectomy
05/2001 - 05/2000